keyword
https://read.qxmd.com/read/38681787/latest-developments-in-early-diagnosis-and-specific-treatment-of-severe-influenza-infection
#41
REVIEW
Francisco Valenzuela-Sánchez, Blanca Valenzuela-Méndez, Juan Francisco Rodríguez-Gutiérrez, Ángel Estella
Influenza pandemics are unpredictable recurrent events with global health, economic, and social consequences. The objective of this review is to provide an update on the latest developments in early diagnosis and specific treatment of the disease and its complications, particularly with regard to respiratory organ failure. Despite advances in treatment, the rate of mortality in the intensive care unit remains approximately 30%. Therefore, early identification of potentially severe viral pneumonia is extremely important to optimize treatment in these patients...
April 2024: J Intensive Med
https://read.qxmd.com/read/38681365/eco-technological-evaluation-of-natural-phytochemicals-potential-drug-molecules-against-main-protease-a-machine-learning-algorithm
#42
JOURNAL ARTICLE
Silambarasan Tamil Selvan, Mukesh Kumar Dharmalingam Jothinathan
Introduction : The global viral pandemic has rapidly spread, leading to many individuals experiencing the infection. Coronaviruses (CoVs) are among many viral families that infect different types of mammals. They can spread to humans and cause gastrointestinal, neurological, and respiratory problems. The present investigation has discovered flavonoid compounds as promising molecular agents with potential antiviral activity against virus proteins, specifically main protease (Mpro). Methodology: A comprehensive in silico screening of natural compounds derived from medicinal plants was performed in the present study...
March 2024: Curēus
https://read.qxmd.com/read/38681127/liver-biopsy-in-the-post-hepatitis-c-virus-era-in-japan
#43
REVIEW
Yoshihiro Ikura, Takako Okubo, Yasuhiro Sakai
In Japan, liver biopsies were previously crucial in evaluating the severity of hepatitis caused by the hepatitis C virus (HCV) and diagnosing HCV-related hepatocellular carcinoma (HCC). However, due to the development of effective antiviral treatments and advanced imaging, the necessity for biopsies has significantly decreased. This change has resulted in fewer chances for diagnosing liver disease, causing many general pathologists to feel less confident in making liver biopsy diagnoses. This article provides a comprehensive overview of the challenges and potential solutions related to liver biopsies in Japan...
April 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38680697/role-of-renin-angiotensin-system-angiotensin-converting-enzyme-2-mechanism-and-enhanced-covid-19-susceptibility-in-type-2-diabetes-mellitus
#44
REVIEW
Ashwin Kumar Shukla, Komal Awasthi, Kauser Usman, Monisha Banerjee
Coronavirus disease 2019 (COVID-19) is a disease that caused a global pandemic and is caused by infection of severe acute respiratory syndrome coronavirus 2 virus. It has affected over 768 million people worldwide, resulting in approximately 6900000 deaths. High-risk groups, identified by the Centers for Disease Control and Prevention, include individuals with conditions like type 2 diabetes mellitus (T2DM), obesity, chronic lung disease, serious heart conditions, and chronic kidney disease. Research indicates that those with T2DM face a heightened susceptibility to COVID-19 and increased mortality compared to non-diabetic individuals...
April 15, 2024: World Journal of Diabetes
https://read.qxmd.com/read/38680655/identifying-citrus-limonoids-as-a-potential-fusion-inhibitor-of-denv-2-virus-through-its-in-silico-study-and-ftir-analysis
#45
JOURNAL ARTICLE
Satyajit Das, Geetartha Sarma, Nithin J Panicker, Partha P Sahu
UNLABELLED: Dengue virus type 2 (DENV-2) is an arthropod-borne deadly RNA human pathogen transmitted through the mosquito Aedes. The DENV-2 roots viral infection by facilitating entry with its envelope glycoprotein to the receptor protein Dendritic-cell-specific ICAM3-grabbing non-integrin (DC-SIGN) through membrane fusion. Here, an organizational path is reported for inhibiting the transition due to fusion activation and by blocking the residues of the DC-SIGN-E-Glyco protein complex through citrus limonoids with its antiviral effect...
2024: In Silico Pharmacology
https://read.qxmd.com/read/38679663/real-world-efficacy-and-safety-of-universal-8-week-glecaprevir-pibrentasvir-for-treatment-na%C3%A3-ve-patients-from-a-nationwide-hcv-registry-in-taiwan
#46
JOURNAL ARTICLE
Chun-Chi Yang, Chung-Feng Huang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chien-Wei Huang, Lee-Won Chong, Pin-Nan Cheng, Ming-Lun Yeh, Cheng-Yuan Peng, Chien-Yu Cheng, Jee-Fu Huang, Ming-Jong Bair, Chih-Lang Lin, Chi-Chieh Yang, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzong-Hsi Lee, Pei-Lun Lee, Wen-Chih Wu, Chih-Lin Lin, Wei-Wen Su, Sheng-Shun Yang, Chia-Chi Wang, Jui-Ting Hu, Lein-Ray Mo, Chun-Ting Chen, Yi-Hsiang Huang, Chun-Chao Chang, Chia-Sheng Huang, Guei-Ying Chen, Chien-Neng Kao, Chi-Ming Tai, Chun-Jen Liu, Mei-Hsuan Lee, Hsing-Tao Kuo, Pei-Chien Tsai, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wang-Long Chuang, Kuo-Chih Tseng, Chi-Yi Chen, Ming-Lung Yu
INTRODUCTION: Eight-week glecaprevir/pibrentasvir (GLE/PIB) is indicated for treatment-naïve (TN) patients with chronic hepatitis C (CHC), with or without compensated cirrhosis. Given that the Taiwanese government is committed to eliminating hepatitis C virus (HCV) by 2025, this study aimed to measure real-world evidence for TN patients using 8-week GLE/PIB in the Taiwan HCV Registry (TACR). METHODS: The data of patients with CHC treated with 8-week GLE/PIB were retrieved from TACR, a nationwide registry program organized by the Taiwan Association for the Study of the Liver (TASL)...
April 28, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38679398/anti-dengue-therapeutic-potential-of-tinospora-cordifolia-and-its-bioactives
#47
REVIEW
Neetu Singh, Surender Singh Yadav
ETHNOPHARMACOLOGICAL RELEVANCE: Dengue is one of the most prevalent mosquito-borne viral infections. Moreover, due to the absence of appropriate curative and preventive measures against it, the mortality rate is increasing alarmingly. However, remarkable docking and clinical advances have been achieved with plant-based natural and conventional therapeutics. Tinospora cordifolia is one of the highly explored panaceas at the local level for its effective anti-dengue formulations. AIM OF THE STUDY: The present article aims for critical assessment of the data available on the anti-dengue therapeutic use of T...
April 26, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38679166/current-and-future-use-of-antibody-based-passive-immunity-to-prevent-or-control-hbv-hdv-infections
#48
REVIEW
Adam J Gehring, Loghman Salimzadeh
With the increasing momentum and success of monoclonal antibody therapy in conventional medical practices, there is a revived emphasis on the development of monoclonal antibodies targeting the hepatitis B surface antigen (anti-HBs) for the treatment of chronic hepatitis B (HBV) and hepatitis D (HDV). Combination therapies of anti-HBs monoclonal antibodies, and novel anti-HBV compounds and immunomodulatory drugs presenting a promising avenue to enhanced therapeutic outcomes in HBV/HDV cure regimens. In this review, we will cover the role of antibodies in the protection and clearance of HBV infection, the association of anti-HBV surface antigen antibodies (anti-HBs) in protection against HBV and how antibody effector functions, beyond neutralization, are likely necessary...
April 26, 2024: Antiviral Research
https://read.qxmd.com/read/38678857/pharmacokinetic-analysis-of-antiviral-drug-ritonavir-across-the-blood-brain-barrier-and-its-interaction-with-scutellaria-baicalensis-using-multisite-microdialysis-in-rats
#49
JOURNAL ARTICLE
Chung-Kai Sun, Yen-Ying Kung, Wan-Hsin Lee, Lie-Chwen Lin, Muh-Hwa Yang, Tung-Hu Tsai
Ritonavir, an excellent inhibitor of CYP3A4, has recently been combined with nirmatrelvir to form Paxlovid for the treatment of severe acute respiratory syndrome coronavirus 2 infections. The root of Scutellaria baicalensis Georgi (S. baicalensis), a traditional Chinese medicinal (TCM) herb commonly used to treat heat/inflammation in the lung and digestive tracts, which are major organs targeted by viral infections, contains flavones that can influence the CYP3A metabolism pathway. To investigate the ability of ritonavir to cross the bloodbrain barrier (BBB) and its potential herb-drug interactions with an equivalent TCM clinical dose of S...
April 18, 2024: Journal of Pharmaceutical and Biomedical Analysis
https://read.qxmd.com/read/38678726/classical-molecular-dynamics-simulation-identifies-catechingallate-as-a-promising-antiviral-polyphenol-against-mpox-palmitoylated-surface-protein
#50
JOURNAL ARTICLE
Sarbani Mishra, Madhusmita Rout, Mahender Kumar Singh, Budheswar Dehury, Sanghamitra Pati
Cumulative global prevalence of the emergent monkeypox (MPX) infection in the non-endemic countries has been professed as a global public health predicament. Lack of effective MPX-specific treatments sets the baseline for designing the current study. This research work uncovers the effective use of known antiviral polyphenols against MPX viral infection, and recognises their mode of interaction with the target F13 protein, that plays crucial role in formation of enveloped virions. Herein, we have employed state-of-the-art machine learning based AlphaFold2 to predict the three-dimensional structure of F13 followed by molecular docking and all-atoms molecular dynamics (MD) simulations to investigate the differential mode of F13-polyphenol interactions...
April 12, 2024: Computational Biology and Chemistry
https://read.qxmd.com/read/38678266/barriers-to-access-to-hepatitis-c-treatment-with-direct-acting-antivirals-in-people-who-inject-drugs-in-the-community-setting
#51
JOURNAL ARTICLE
Elena Yela, Neus Solé, Lidia Puig, Darío López Gallegos, Rafael Clua-García
Barriers to access to hepatitis C treatment with direct-acting antivirals in people who inject drugs in the community setting. Qualitative study with prison population. Hepatitis C (HCV) treatments with direct-acting antiviral therapy (DAA) are an easy and effective option among people who inject drugs (PWID). However, difficulties in accessing and monitoring treatment in community services and dropouts on release from prison are detected among PWID. For this reason, the aim of the study is to know the access barriers in the diagnosis and treatment of HCV in community health services...
April 27, 2024: Harm Reduction Journal
https://read.qxmd.com/read/38677668/exploring-carrageenan-from-seaweed-to-biomedicine-a-comprehensive-review
#52
REVIEW
Itishree Jogamaya Das, Trishna Bal
Biomaterials are pivotal in the realms of tissue engineering, regenerative medicine, and drug delivery and serve as fundamental building blocks. Within this dynamic landscape, polymeric biomaterials emerge as the frontrunners, offering unparalleled versatility across physical, chemical, and biological domains. Natural polymers, in particular, captivate attention for their inherent bioactivity. Among these, carrageenan (CRG), extracted from red seaweeds, stands out as a naturally occurring polysaccharide with immense potential in various biomedical applications...
April 25, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38677595/sars-cov-2-evolution-has-increased-resistance-to-monoclonal-antibodies-and-first-generation-covid-19-vaccines-is-there-a-future-therapeutic-role-for-soluble-ace2-receptors-for-covid-19
#53
REVIEW
Rohan Ameratunga, Anthony Jordan, Klaus Lehnert, Euphemia Leung, Emily R Mears, Russell Snell, Richard Steele, See-Tarn Woon
COVID-19 has caused calamitous health, economic and societal consequences. Although several COVID-19 vaccines have received full authorization for use, global deployment has faced political, financial and logistical challenges. The efficacy of first-generation COVID-19 vaccines is waning and breakthrough infections are allowing ongoing transmission and evolution of SARS-CoV-2. Furthermore, COVID-19 vaccine efficacy relies on a functional immune system. Despite receiving three primary doses and three or more heterologous boosters, some immunocompromised patients may not be adequately protected by COVID-19 vaccines and remain vulnerable to severe disease...
April 25, 2024: Antiviral Research
https://read.qxmd.com/read/38677300/temporal-changes-in-sars-cov-2-clearance-kinetics-and-the-optimal-design-of-antiviral-pharmacodynamic-studies-an-individual-patient-data-meta-analysis-of-a-randomised-controlled-adaptive-platform-study-platcov
#54
JOURNAL ARTICLE
Phrutsamon Wongnak, William H K Schilling, Podjanee Jittamala, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M Batty, Shivani Singh, Jindarat Kouhathong, Watcharee Pagornrat, Patpannee Khanthagan, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Mayfong Mayxay, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Elizabeth A Ashley, Arjen M Dondorp, Nicholas P J Day, Mauro M Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J White, James A Watson
BACKGROUND: Effective antiviral drugs prevent hospitalisation and death from COVID-19. Antiviral efficacy can be efficiently assessed in vivo by measuring rates of SARS-CoV-2 clearance estimated from serial viral genome densities quantitated in nasopharyngeal or oropharyngeal swab eluates. We conducted an individual patient data meta-analysis of unblinded arms in the PLATCOV platform trial to characterise changes in viral clearance kinetics and infer optimal design and interpretation of antiviral pharmacometric evaluations...
April 24, 2024: Lancet Infectious Diseases
https://read.qxmd.com/read/38677125/identification-critical-host-factors-for-japanese-encephalitis-virus-replication-via-crispr-screening-of-human-sgrna-library
#55
JOURNAL ARTICLE
Le-le Liu, You-Qin Yin, Kai-Xiong Ma, Jin-Chao Xing, Xing-Xing Ren, Jin-Yu Huang, Ming Liao, Wen-Bao Qi, Li-Hong Huang
Japanese encephalitis virus (JEV) is a pathogen with a substantial impact on both livestock and human health. However, the critical host factors in the virus life cycle remain poorly understood. Using a library comprising 123411 small guide RNAs (sgRNAs) targeting 19050 human genes, we conducted a genome-wide clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-based screen to identify essential genes for JEV replication. By employing knockout or knockdown techniques on genes, we identified eleven human genes crucial for JEV replication, such as prolactin releasing hormone receptor (PRLHR), activating signal cointegrator 1 complex subunit 3 (ASCC3), acyl-CoA synthetase long chain family member 3 (ACSL3), and others...
April 24, 2024: Veterinary Microbiology
https://read.qxmd.com/read/38676613/towards-greener-and-more-cost-efficient-biosynthesis-of-pharmaceuticals-and-fragrance-molecules
#56
REVIEW
Ana I Benítez Mateos
Enzymes are natural catalysts which are gaining momentum in chemical synthesis due to their exquisiteselectivity and their biodegradability. However, the cost-efficiency and the sustainability of the overall biocatalytic process must be enhanced to unlock completely the potential of enzymes for industrial applications. To reach this goal, enzyme immobilization and the integration into continuous flow reactors have been the cornerstone of our research. We showed key examples of the advantages of those tools for the biosynthesis of antivirals, anticancer drugs, and valuable fragrance molecules...
April 24, 2024: Chimia
https://read.qxmd.com/read/38676291/viral-kinetics-model-of-sars-cov-2-infection-informs-drug-discovery-clinical-dose-and-regimen-selection
#57
JOURNAL ARTICLE
Allison M Claas, Meelim Lee, Pai-Hsi Huang, Charles G Knutson, Domenico Bullara, Birgit Schoeberl, Suzanne Gaudet
Quantitative systems pharmacology (QSP) has been an important tool to project safety and efficacy of novel or repurposed therapies for the SARS-CoV-2 virus. Here, we present a QSP modeling framework to predict response to antiviral therapeutics with three mechanisms of action (MoA): cell entry inhibitors, anti-replicatives, and neutralizing biologics. We parameterized three distinct model structures describing virus-host interaction by fitting to published viral kinetics data of untreated COVID-19 patients...
April 26, 2024: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38675992/why-certain-repurposed-drugs-are-unlikely-to-be-effective-antivirals-to-treat-sars-cov-2-infections
#58
JOURNAL ARTICLE
Selwyn J Hurwitz, Ramyani De, Julia C LeCher, Jessica A Downs-Bowen, Shu Ling Goh, Keivan Zandi, Tamara McBrayer, Franck Amblard, Dharmeshkumar Patel, James J Kohler, Manoj Bhasin, Brian S Dobosh, Vikas Sukhatme, Rabindra M Tirouvanziam, Raymond F Schinazi
Most repurposed drugs have proved ineffective for treating COVID-19. We evaluated median effective and toxic concentrations (EC50 , CC50 ) of 49 drugs, mostly from previous clinical trials, in Vero cells. Ratios of reported unbound peak plasma concentrations, (Cmax )/EC50 , were used to predict the potential in vivo efficacy. The 20 drugs with the highest ratios were retested in human Calu-3 and Caco-2 cells, and their CC50 was determined in an expanded panel of cell lines. Many of the 20 drugs with the highest ratios were inactive in human Calu-3 and Caco-2 cells...
April 22, 2024: Viruses
https://read.qxmd.com/read/38675980/the-dual-targeted-fusion-inhibitor-clofazimine-binds-to-the-s2-segment-of-the-sars-cov-2-spike-protein
#59
JOURNAL ARTICLE
Matthew R Freidel, Pratiti A Vakhariya, Shalinder K Sardarni, Roger S Armen
Clofazimine and Arbidol have both been reported to be effective in vitro SARS-CoV-2 fusion inhibitors. Both are promising drugs that have been repurposed for the treatment of COVID-19 and have been used in several previous and ongoing clinical trials. Small-molecule bindings to expressed constructs of the trimeric S2 segment of Spike and the full-length SARS-CoV-2 Spike protein were measured using a Surface Plasmon Resonance (SPR) binding assay. We demonstrate that Clofazimine, Toremifene, Arbidol and its derivatives bind to the S2 segment of the Spike protein...
April 20, 2024: Viruses
https://read.qxmd.com/read/38675973/dmso-and-its-role-in-differentiation-impact-efficacy-of-human-adenovirus-hadv-infection-in-heparg-cells
#60
JOURNAL ARTICLE
Katharina Hofmann, Samuel Hofmann, Franziska Weigl, Julia Mai, Sabrina Schreiner
Differentiated HepaRG cells are popular in vitro cell models for hepatotoxicity studies. Their differentiation is usually supported by the addition of dimethyl sulfoxide (DMSO), an amphipathic solvent widely used in biomedicine, for example, in potential novel therapeutic drugs and cryopreservation of oocytes. Recent studies have demonstrated drastic effects, especially on epigenetics and extracellular matrix composition, induced by DMSO, making its postulated inert character doubtful. In this work, the influence of DMSO and DMSO-mediated modulation of differentiation on human adenovirus (HAdV) infection of HepaRG cells was investigated...
April 19, 2024: Viruses
keyword
keyword
118970
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.